INGELHEIM, Germany — (BUSINESS WIRE) — Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for wh…
Boehringer Ingelheim sees positive business momentum in 2020 despite impact of COVID-19
INGELHEIM, Germany — (BUSINESS WIRE) — Boehringer Ingelheim stepped up its investments in R&D significantly in 2020 in pursuit of innovative medicines and therapies for diseases for wh…